| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.008 |